Erratum to “Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach”

Cynthia D.J. Kusters; Kimberly C. Paul; Aline Duarte Folle; Adrienne M. Keener; Jeff M. Bronstein; Lars Bertram; Johnni Hansen; Steve Horvath; Janet S. Sinsheimer; Christina M. Lill; Beate R. Ritz

doi:10.1002/mds.28974

Erratum to “Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach”

Cynthia D.J. Kusters^*, Kimberly C. Paul, Aline Duarte Folle, Adrienne M. Keener, Jeff M. Bronstein, Lars Bertram, Johnni Hansen, Steve Horvath, Janet S. Sinsheimer, Christina M. Lill, Beate R. Ritz

^*Corresponding author for this work

Original language	English
Journal	Movement Disorders
Volume	37
Issue number	6
Pages (from-to)	1282-1283
Number of pages	2
ISSN	0885-3185
DOIs	https://doi.org/10.1002/mds.28974
Publication status	Published - 06.2022

Access to Document

10.1002/mds.28974

Cite this

@article{04566a0b831248e9b0ad0edffe47ea59,

title = "Erratum to “Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach”",

author = "Kusters, {Cynthia D.J.} and Paul, {Kimberly C.} and {Duarte Folle}, Aline and Keener, {Adrienne M.} and Bronstein, {Jeff M.} and Lars Bertram and Johnni Hansen and Steve Horvath and Sinsheimer, {Janet S.} and Lill, {Christina M.} and Ritz, {Beate R.}",

note = "Funding Information: C.M.L. and L.B. received funding from the German Research Foundation for the genome‐wide SNP data generation and processing of the PEG and PASIDA GWAS data (DFG; FOR2488/1: LI 2654/2‐1 and BE 2287/5‐1). C.M.L. received support by a “habilitation grant” (H01‐2019) from the University of L{\"u}beck. J.S.S. was partially funded by NIH/NHGRI grant HG009120. This project has been made available with funding from National Institutes of Health (NIH) grants R01‐ES010544, R01‐ES013717, U54‐ES012078, P01‐ES016732, and P50‐NS038367; initial pilot funding from NIH P30‐ES07048; a Community Fast Track grant by the MJFox Foundation; a pilot grant by the American Parkinson Disease Association; and from the Parkinson's Alliance. C.K. is supported by the NIH grant F32AG063442. Funding Information: Cynthia Kusters: is supported by the NIH grant F32AG063442, and employed in the department of Human Genetics as a Ruth Kirchstein postdoctoral fellow (under the NIH F32 grant) at the University of California, Los Angeles. Kimberly Paul: is supported by the NIH grant R21ES030175, K01AG072044, and the Department of Defense grant W81XWH1910697. She is employed in the department of Epidemiology as a postdoctoral fellow at the University of California, Los Angeles. Aline Duarte Folle: She is currently a postdoctoral employee, funded by a Multiple System Atrophy Coalition grant CoreE‐2020‐08‐001 and by NIH R01 ES31106‐01A1. Adrienne Keener: is employed by the Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, and department of Neurology at the University of California, Los Angeles. She is on the Medical Advisory Board for 2 non‐profit patient groups: Parkinson's Community Los Angeles and Down with Dystonia. Lars Bertram: is employed by the University of L{\"u}beck, L{\"u}beck, Germany; and the University of Oslo, Oslo, Norway. He is funded by the following grants: Deutsche Forschungsgemeinschaft, Cure Alzheimer's Fund, and the European Research Council. He has given expert testimony for the Research Council of Norway. He also has a contract with Massachusetts General Hospital / Harvard Medical School. Johnni Hansen: is supported by the following grants: NORDFORSK, RT‐10; Nordic Cancer Union. No number; NIEHS 1 R21 NS099910; NIEHS 1 R21 ES028472‐01A1; UCLA, Alpha‐1 Foundation, 611519. He is employed by the Danish Cancer Society. Steve Horvath: was employed as a Professor by the Department of Human Genetics at the University of California, Los Angeles. He recently started a position at Altos Labs, San Diego Institute of Science. He has patents for “DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY”; U.S. Provisional Patent Application Serial Number 62/744,010 (reference: G&C 30435.361‐US‐P1), and for “DNA METHYLATION BASED ESTIMATOR OF TELOMERE LENGTH” (reference: 30435.0374WOU1). He consults for Iduna Inc; is on the advisory board of the Epigenetic Clock Development Foundation – founder of non‐profit foundation, and is supported by the NIH 1U01AG060908 –01 grant. Jeff Bronstein: is employed as a Professor by the Department of Neurology at the University of California, Los Angeles. He performs Ultragenyx pre‐clinical consultations, and is an advisor to the internal education program of Alexion. He is supported by the following grants: Levine Foundation. Clinical Trials Site PI for these trials: Alexion (Wilson's disease trial); US World Meds (apomorphine infusion for treatment of PD; Abbvie, levodopa infusion for the treatment of PD. Janet Sinsheimer: has been or is supported by NIH grants HG007703, HG009120, GM053275, and ES023451 and employed as a Professor by the Department of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles. She is a member of the Data Safety and Monitoring Board for the MPS 1 Intrathecal Research Collaborative Project. She has received royalties from US Patent App. 14/119,145. J.S.S. was partially funded by NIH/NHGRI grant HG009120. Christina Lill: is employed by the University Hospital Schleswig‐Holstein, L{\"u}beck, Germany; and the Imperial College London, London, UK. She is supported by grants from Michael J Fox Foundation, Deutsche Forschungsgemeinschaft, Cure Alzheimer's Fund, and the European Research Council. Beate Ritz: is employed as a professor in the departments of Epidemiology, Environmental Health Sciences, and Neurology at the University of California, Los Angeles. She is being supported by NIH grants (U01AG060908, R21ES030175, R01ES023451, and R01ES031106), and by grants from the Department of Defense (W81XWH1910697), the MJFox foundation, the California State Air Resources Board, a contract from NASA (NNH12ZDA006O‐EVI3), and a training grant by the BURROUGHS WELLCOME FUND. She also has been an expert witness for plaintiffs (farmers) in law suits linking pesticide exposures to health outcomes. ",

year = "2022",

month = jun,

doi = "10.1002/mds.28974",

language = "English",

volume = "37",

pages = "1282--1283",

journal = "Movement Disorders",

issn = "0885-3185",

number = "6",

}

TY - JOUR

T1 - Erratum to “Increased Menopausal Age Reduces the Risk of Parkinson's Disease

T2 - A Mendelian Approach”

AU - Kusters, Cynthia D.J.

AU - Paul, Kimberly C.

AU - Duarte Folle, Aline

AU - Keener, Adrienne M.

AU - Bronstein, Jeff M.

AU - Bertram, Lars

AU - Hansen, Johnni

AU - Horvath, Steve

AU - Sinsheimer, Janet S.

AU - Lill, Christina M.

AU - Ritz, Beate R.

N1 - Funding Information: C.M.L. and L.B. received funding from the German Research Foundation for the genome‐wide SNP data generation and processing of the PEG and PASIDA GWAS data (DFG; FOR2488/1: LI 2654/2‐1 and BE 2287/5‐1). C.M.L. received support by a “habilitation grant” (H01‐2019) from the University of Lübeck. J.S.S. was partially funded by NIH/NHGRI grant HG009120. This project has been made available with funding from National Institutes of Health (NIH) grants R01‐ES010544, R01‐ES013717, U54‐ES012078, P01‐ES016732, and P50‐NS038367; initial pilot funding from NIH P30‐ES07048; a Community Fast Track grant by the MJFox Foundation; a pilot grant by the American Parkinson Disease Association; and from the Parkinson's Alliance. C.K. is supported by the NIH grant F32AG063442. Funding Information: Cynthia Kusters: is supported by the NIH grant F32AG063442, and employed in the department of Human Genetics as a Ruth Kirchstein postdoctoral fellow (under the NIH F32 grant) at the University of California, Los Angeles. Kimberly Paul: is supported by the NIH grant R21ES030175, K01AG072044, and the Department of Defense grant W81XWH1910697. She is employed in the department of Epidemiology as a postdoctoral fellow at the University of California, Los Angeles. Aline Duarte Folle: She is currently a postdoctoral employee, funded by a Multiple System Atrophy Coalition grant CoreE‐2020‐08‐001 and by NIH R01 ES31106‐01A1. Adrienne Keener: is employed by the Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, and department of Neurology at the University of California, Los Angeles. She is on the Medical Advisory Board for 2 non‐profit patient groups: Parkinson's Community Los Angeles and Down with Dystonia. Lars Bertram: is employed by the University of Lübeck, Lübeck, Germany; and the University of Oslo, Oslo, Norway. He is funded by the following grants: Deutsche Forschungsgemeinschaft, Cure Alzheimer's Fund, and the European Research Council. He has given expert testimony for the Research Council of Norway. He also has a contract with Massachusetts General Hospital / Harvard Medical School. Johnni Hansen: is supported by the following grants: NORDFORSK, RT‐10; Nordic Cancer Union. No number; NIEHS 1 R21 NS099910; NIEHS 1 R21 ES028472‐01A1; UCLA, Alpha‐1 Foundation, 611519. He is employed by the Danish Cancer Society. Steve Horvath: was employed as a Professor by the Department of Human Genetics at the University of California, Los Angeles. He recently started a position at Altos Labs, San Diego Institute of Science. He has patents for “DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY”; U.S. Provisional Patent Application Serial Number 62/744,010 (reference: G&C 30435.361‐US‐P1), and for “DNA METHYLATION BASED ESTIMATOR OF TELOMERE LENGTH” (reference: 30435.0374WOU1). He consults for Iduna Inc; is on the advisory board of the Epigenetic Clock Development Foundation – founder of non‐profit foundation, and is supported by the NIH 1U01AG060908 –01 grant. Jeff Bronstein: is employed as a Professor by the Department of Neurology at the University of California, Los Angeles. He performs Ultragenyx pre‐clinical consultations, and is an advisor to the internal education program of Alexion. He is supported by the following grants: Levine Foundation. Clinical Trials Site PI for these trials: Alexion (Wilson's disease trial); US World Meds (apomorphine infusion for treatment of PD; Abbvie, levodopa infusion for the treatment of PD. Janet Sinsheimer: has been or is supported by NIH grants HG007703, HG009120, GM053275, and ES023451 and employed as a Professor by the Department of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles. She is a member of the Data Safety and Monitoring Board for the MPS 1 Intrathecal Research Collaborative Project. She has received royalties from US Patent App. 14/119,145. J.S.S. was partially funded by NIH/NHGRI grant HG009120. Christina Lill: is employed by the University Hospital Schleswig‐Holstein, Lübeck, Germany; and the Imperial College London, London, UK. She is supported by grants from Michael J Fox Foundation, Deutsche Forschungsgemeinschaft, Cure Alzheimer's Fund, and the European Research Council. Beate Ritz: is employed as a professor in the departments of Epidemiology, Environmental Health Sciences, and Neurology at the University of California, Los Angeles. She is being supported by NIH grants (U01AG060908, R21ES030175, R01ES023451, and R01ES031106), and by grants from the Department of Defense (W81XWH1910697), the MJFox foundation, the California State Air Resources Board, a contract from NASA (NNH12ZDA006O‐EVI3), and a training grant by the BURROUGHS WELLCOME FUND. She also has been an expert witness for plaintiffs (farmers) in law suits linking pesticide exposures to health outcomes.

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85125592962&partnerID=8YFLogxK

U2 - 10.1002/mds.28974

DO - 10.1002/mds.28974

M3 - Journal articles

C2 - 35245402

AN - SCOPUS:85125592962

SN - 0885-3185

VL - 37

SP - 1282

EP - 1283

JO - Movement Disorders

JF - Movement Disorders

IS - 6

ER -

Erratum to “Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Approach”

Access to Document

Other files and links

Cite this